✦ LIBER ✦

Open-label, dose-escalation, safety, pharmacokinetic, and pharmacodynamic study of intravenously administered CNF1010 (17-(allylamino)-17-demethoxygeldanamycin [17-AAG]) in patients with solid tumors

✍ Scribed by M. W. Saif, C. Erlichman, T. Dragovich…

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase 1 open-label, sequential dose-es

✍ Ghamande, Sharad; Lin, Chia-Chi; Cho, Daniel C.; Shapiro, Geoffrey I.; Kwak, Eun 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 318 KB

411 POSTER A phase I, open-label, dose-e

✍ R. Salgia; A. Peterson; S. Eppler; W. Yu; B. Polite; D. Geary; E. Wesolowski; M. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 61 KB